Background: Candida albicans is a common opportunistic pathogen of the human body and is the frequent causative agent of candidiasis. Typically, these infections are associated with the formation of biofilms on both host tissues and implanted biomaterials. As a result of the intrinsic resistance of C. albicans biofilms to most antifungal agents, new strategies are needed to combat these infections.
Introduction
Candida species are opportunistic pathogenic yeasts in humans that are capable of causing a variety of infections in susceptible patients, ranging from mucosal to life-threatening systemic candidiasis. The increase of Candida infections parallels medical advancements such as invasive procedures, immunosuppressive treatments for organ transplants and widespread use of broadspectrum antibiotics. Candida albicans is the most common species associated with candidiasis and is the most frequently recovered species from hospitalized patients. 1 Candidiasis is the fourth leading blood-borne infection, with mortality rates as high as 47%. 2 In its normal niche, C. albicans forms biofilms that are attached to surfaces. 3 -6 In addition to mucosal surfaces, these biofilms attach to implanted medical devices, such as intravenous catheters, shunts, stents, etc. 5, 7 Biofilms are structured microbial communities attached to a surface and encased in a self-produced exopolymeric matrix. 5, 7 The stages of biofilm formation consist of the adherence of yeast cells to the surface and the establishment of a monolayer of cells, followed by proliferation, filamentation and maturation. 3, 6 Fully mature C. albicans biofilms are a complex network of yeast, hyphae and pseudohyphae encased within an extracellular matrix. 6, 8 C. albicans biofilms exhibit increased resistance to antifungal agents such as fluconazole and amphotericin B and host immune defences. 6, 8, 9 Tunicamycin is a nucleoside antibiotic produced by Streptomyces lysosuperficus that blocks N-linked glycosylation and the formation of N-glycosidic protein -carbohydrate linkages in eukaryotic cells, including yeasts. 10 Specifically, tunicamycin blocks the transfer of GlcNAc-1-P from UDP-GlcNAc to dolichol phosphate, the first step in the synthesis of N-linked oligosaccharide chains on mannoproteins. These mannoproteins are major components of C. albicans cell walls and secreted materials, and play important structural and functional roles during host -pathogen interactions. 11 -13 Moreover, Candida cell wall mannosylation has been suggested as an attractive potential target for the development of antifungal drugs. 14 Under the biofilm mode of growth, some of these mannoproteins are important components of the biofilm matrix. Previous results from our laboratory 15 indicate that two important mannoproteins, Mp65 (Scw1/orf19.1779) and Mp58 (Pra1/orf19.3111), 16, 17 represent major components of the C. albicans biofilm matrix. They may contribute a high proportion of the carbohydrate component of the matrix due to high levels of glycosylation and may play important roles during biofilm development and maintenance. Based on its inhibitory role in N-linked glycosylation, we hypothesize that tunicamycin may have an effect on C. albicans biofilm development.
Materials and methods

Drugs
Tunicamycin was obtained as a powder from Sigma, St Louis, MO, USA. A stock solution of 40 mg/mL tunicamycin was prepared in DMSO and stored at 48C until used. Subsequent dilutions of tunicamycin were made in RPMI-1640 supplemented with L-glutamine and buffered with MOPS (Angus Buffers and Chemicals, Niagara Falls, NY, USA).
Strain, media and culture conditions
The C. albicans yeast strain used in the present study was wild-type strain SC5314. Cells were stored at 2708C as glycerol stocks and propagated by streaking a loopful of cells onto yeast peptone dextrose (YPD) agar [1% (w/v) yeast extract, 2% (w/v) peptone, 2% (w/v) dextrose] and incubating overnight at 378C. Flasks (150 mL) containing 20 mL of YPD liquid medium were then inoculated with a loopful of cells from YPD agar plates and grown overnight in an orbital shaker (150 -180 rpm) at 308C. Under these conditions, this strain grows as budding yeast. The cells were harvested from overnight YPD cultures (growing in the yeast form) and washed twice in sterile PBS [10 mM phosphate buffer, 2.7 mM potassium chloride, 137 mM sodium chloride ( pH 7.4) (Sigma)] by centrifugation at 3000 g. The cells were then resuspended in RPMI. Dilutions (100-fold) of the suspended cells were prepared and counted using a haemocytometer on a bright field microscope. Subsequently, the desired cell concentrations were prepared in RPMI (2.0Â10 6 cells/mL for biofilms grown in the presence or absence of tunicamycin, and 1.0Â10 6 cells/mL for biofilms pre-formed and later treated with tunicamycin; discussed subsequently).
C. albicans biofilm formation and examination of the inhibitory effect of tunicamycin C. albicans biofilms were formed on commercially available presterilized, polystyrene, flat-bottomed, 96-well microtitre plates (Corning Inc., Corning, NY, USA) following the general methodology previously described by our group. 18 RPMI medium (50 mL) containing tunicamycin in 2-fold increments ranging from 128 to 0.5 mM was added to the wells in the first nine columns of the microtitre plate. In addition, one column contained 50 mL of RPMI without tunicamycin to serve as a positive control for biofilm growth (a series of preliminary experiments indicated that biofilm formation was not affected by the presence of up to 1% DMSO), and the final two columns remained empty to serve as a negative background control for subsequent analysis and quantification. Subsequently, 50 mL of the standardized C. albicans cell suspension (2.0Â10 6 cells/mL) was added to each well with the exception of the blanks (negative control columns). The microtitre plate was covered with its lid, sealed with parafilm and incubated at 378C for 24 h.
Examination of the inhibitory effect of tunicamycin on pre-formed C. albicans biofilms C. albicans biofilms were pre-formed in microtitre plates by adding 100 mL of standardized cell suspension (1.0Â10 6 cells/mL) to the first 10 columns of the microtitre plate. The final two columns remained empty to serve as a negative control. The microtitre plate was covered with its lid, sealed with parafilm and incubated at 378C for 24 h. The wells were then washed twice with sterile PBS and 100 mL of RPMI containing tunicamycin in serially double-diluted concentrations ranging from 128 to 0.5 mM was added to the wells of the first nine columns of the microtitre plate. RPMI medium (100 mL) without tunicamycin was added to the 10th column to serve as a positive control for biofilm growth, and the final two columns remained empty. The microtitre plate was covered with its lid, sealed with parafilm and incubated at 378C for an additional 24 h.
XTT [2,3-bis(2-methoxy-4-nitro-5-sulfo-phenyl)-2H-tetrazolium-5-carboxanilide] reduction assay After incubating the plates for the appropriate period (as above), the RPMI medium was removed and wells washed three times with sterile PBS (200 mL per well). Residual PBS was removed by blotting with paper towels. Semi-quantification of the fungal cell viability in wells of microtitre plates was calculated using a colorimetric XTT reduction assay as previously described by our group. 18 This assay relies on the reduction of XTT by metabolically active cells to yield a water-soluble formazan coloured product that can be measured in a microtitre plate reader. XTT (Sigma) was prepared in a saturated solution at 0.5 g/L in Ringer's lactate. The solution was filter sterilized with a filter with a pore size of 0.22 mm, aliquoted and stored at 2708C. Prior to each assay, an aliquot of stock XTT was thawed and menadione (Sigma; 10 mM prepared in acetone) was added to a final concentration of 1 mM. XTT-menadione solution (80 mL) was added to each pre-washed biofilm and control wells (serve as background measurement). The microtitre plates were incubated in the dark at 378C for 2 h. Following incubation, 75 mL of XTT -menadione solution was transferred to a new microtitre plate and the colorimetric change from XTT reduction was read in a microtitre plate reader (Benchmark Microplate Reader; Bio-Rad, Hercules, CA, USA) at 490 nm.
Microscopy
Bright-field light microscopy techniques on an inverted system microscope (Westover Scientific, Mill Creek, WA, USA) equipped for photography were used to monitor biofilm formation on the wells of microtitre plates. The images were processed for display using Micron software (Westover Scientific).
Two-dimensional gel electrophoresis (2DE) and ELISA to assess the tunicamycin effect on glycosylation of cell surface proteins extracted from C. albicans biofilms C. albicans biofilms were formed in tissue culture flasks over 24 h at 378C as previously described by our group, 15, 19 in the presence and absence of tunicamycin at concentrations of 1 and 2 mM. Cell surface/secreted mannoproteins were solubilized by treatment with b-mercaptoethanol (bME) as previously described by our group. 15 Briefly, cells were washed with PBS, resuspended in ammonium carbonate buffer containing 1% (v/v) bME and incubated at 378C for 45 min with gentle agitation. After treatment, the cells were centrifuged, and the supernatant fluid was recovered and processed through a Millipore Ultrafree-15 centrifugal filter device for desalting and concentration. For 2DE separations, immobilized pH gradient strips (11 cm, pH 4-7) (Bio-Rad) were rehydrated for 16 h at 208C in 200 mL of rehydration/sample buffer containing C. albicans bME extracts ($250 mg expressed as total protein). Isoelectric focusing was carried out using the PROTEAN IEF (Bio-Rad) under the following conditions: step 1, 250 V for 20 min; step 2, increased to 8000 V over 2.5 h; and step 3, 8000 V for a total of 30000 V/h. Strips were then placed into equilibration buffer and disulphide groups were subsequently blocked with iodacetamide. Equilibrated IPG strips were then placed and fixed using hot agarose on the top of SDS-PAGE 12.5% polyacrylamide Criterion Precast Gels (Bio-Rad), and separation of proteins in the second dimension was carried out under reducing conditions. After electrophoresis, protein spots were visualized by staining with SYPRO w Ruby (Bio-Rad) following the manufacturer's instructions. Gel comparison analysis was performed by PDQuest (Bio-Rad). An ELISA was also performed to corroborate the effect of tunicamycin on glycosylation of C. albicans mp58, a cell surface/secreted mannoprotein present in the surface and matrix of cells in biofilms and previously identified by our group as an immunodominant antigen. Briefly, equal amounts (by protein estimates) of bME extracts from control and tunicamycin-treated cells were used to coat different wells of Immulon 2 plates (Thermo Fisher Scientific, Waltham, MA, USA) in a carbonate buffer ( pH 9.6). Then, MAb 3H3, which recognises a peptidic epitope at the C-terminus of the protein moiety of mp58 20 and MAb 1H4, which recognises a carbohydrate epitope in cell wall mannoproteins 21 were added to the corresponding wells at a 1:1000 dilution in PBS with 0.05% Tween 20 (PBST) and 1% BSA, and the plates were incubated at 378C for 1 h. After washing the plates were incubated with peroxidase-conjugated goat anti-mouse IgG (Bio-Rad, at 1:2000 dilution in PBST with 1% BSA) at 378C for 1 h. After washing, the plates were developed with o-phenylenediamine in citrate buffer and read at 490 nm in a microtitre plate reader (Bio-Rad).
Statistical analyses
All experiments using microtitre plates were repeated at least twice with four to eight replicates for each condition tested, with similar results. Average optical density (OD) values were calculated from multiple replicate wells for a given condition for XTT readings, and background was eliminated by subtracting the OD of the blank wells. The inhibitory effect of tunicamycin was expressed as the percentage of the OD in tunicamycin-treated wells compared with that of control (untreated) wells. The effect of tunicamycin treatments when compared with control wells was assessed by using Student's t-test. P,0.05 was considered as statistically significant. The analyses were performed using GraphPad Prism version 4.0 for Windows (GraphPad Software, San Diego, CA, USA).
Results and discussion
Tunicamycin displays an inhibitory effect on C. albicans biofilm formation
Because of the effects of tunicamycin on N-glycosylation of C. albicans mannoproteins, 10, 17, 22, 23 we hypothesized that this compound may affect the development of C. albicans biofilms. Glycosylation of C. albicans mannoproteins is likely to influence structural and functional roles, including adhesion, cellcell and matrix interactions, which are deemed to be important in biofilm formation, development and maintenance. 6,24 -28 In addition, tunicamycin affects the formation of hyphae by C. albicans, 29 and filamentation plays a pivotal role in biofilm formation. 25, 26, 30, 31 Thus, a series of experiments were designed to directly test the potential inhibitory effects of tunicamycin on C. albicans biofilm formation using the 96-well microtitre plate method of biofilm formation previously described by our group. Results indicated that tunicamycin shows a potent inhibitory effect on C. albicans SC5314 biofilm formation under the Tunicamycin (µM) % Biofilm formation Figure 1 . Effect of tunicamycin on C. albicans SC5314 biofilm formation. Biofilms were formed in the presence of different tunicamycin concentrations using the 96-well microtitre plate model, incubated for 24 h, washed and then assessed using the colorimetric XTT reduction assay. The results are expressed as a percentage of the control biofilm (no tunicamycin). *Statistically significant differences, P,0.01. conditions used in these experiments. At virtually all concentrations tested, except for the lowest (0.5 mM), tunicamycin led to sharp reductions in biofilm formation using the semiquantitative XTT reduction assay to measure the metabolic activity of cells within the biofilm (Figure 1 ). High concentrations of tunicamycin (32-128 mM) led to .90% inhibition of biofilm formation. These high concentrations can be considered supraphysiological, and besides their effects on N-glycosylation, they may lead to non-specific effects on general fungal growth. In fact, this was the case and microscopic examination of wells prior to washing indicated both lack of growth and filamentation at these concentrations (not shown). Tunicamycin concentrations ,16 mM can be considered physiological and have been traditionally used in the C. albicans literature. 17, 22, 23, 29 In our experiments, most of these tunicamycin concentrations also led to dramatic decreases in biofilm formation. For example, biofilms grown in the presence of 4 mM tunicamycin resulted in a 70% decrease in XTT readings when compared with the control (Figure 1) . However, close microscopic examination of cells in the wells pre-and post-washing, indicated that under the parameters used in these experiments (strain, medium and growing conditions) tunicamycin concentrations of 16, 8 and 4 mM still exerted a general inhibitory effect on fungal growth and filamentation, although rudimentary filaments could be observed in the presence of 4 mM tunicamycin (Figure 2 ). Tunicamycin concentrations of 2 and 1 mM still led to .90% reduction in XTT readings, but at these concentrations the drug did not display any noticeable effects on cell growth and morphology (compared with the control) ( Figure 2) . As demonstrated by direct microscopic examinations of cells in the wells pre-and post-washing for biofilm processing, it would seem that at these tunicamycin concentrations (2 and 1 mM), C. albicans SC5314 was able to initially form biofilms mostly resembling the control biofilms before washing; however, when the biofilms were washed with PBS, the biofilms did not remain attached to the microtitre plate surface (Figure 2f and h) resulting in low or no ODs when processed with XTT. At 0.5 mM tunicamycin, C. albicans SC5314 formed a biofilm resembling the control biofilm, showing no decrease in cell density or metabolism and remained adhered to the surface of the plate after washing (Figure 2i and j) .
Pre-formed C. albicans biofilms display high levels of resistance to tunicamycin
One of the main consequences of biofilm formation, with important clinical consequences, is the increased resistance of sessile cells to antibiotic treatment. 5, 6 In the case of C. albicans, our group and others have demonstrated that pre-formed biofilms display high levels of resistance against both azoles (i.e. fluconazole) and polyenes (i.e. amphotericin B), the most commonly used antifungal agents. 3, 8, 18, 32 However, caspofungin, a new antifungal agent belonging to the echinocandin class that targets cell wall biosynthesis, more specifically b-glucan synthesis, exhibits potent activity against C. albicans biofilms in vitro. 33, 34 In order to examine the activity of tunicamycin against pre-formed biofilms, C. albicans strain SC5314 biofilms were grown in wells of microtitre plates for 24 h, and these pre-formed biofilms were subsequently exposed to different concentrations of tunicamycin for an additional 24 h. Although statistically significant differences between tunicamycin-treated versus non-treated (control) biofilms were detected as indicated by the XTT readings, no single concentration of tunicamycin used in these experiments led to a .50% reduction in biofilm formation (Figure 3) , thus indicating high levels of resistance of pre-formed biofilms against tunicamycin using the same criteria that has been applied to the study of the activity of fluconazole and other antifungal agents against biofilms. 3, 18 At concentrations !4 mM, there was a 30% and 40% reduction in XTT readings (P,0.01 versus control). At 2 mM (the concentration of tunicamycin that had an effect on developing biofilms in the previous experiment but no apparent effect on cell growth and filamentation) there was approximately a 15% reduction in metabolically active cells compared with control biofilms (P, 0.05). Tunicamycin concentrations of 1 mM and lower had no statistically significant effects on pre-formed biofilms. Confirming these results, microscopic evaluation of the biofilms showed little difference between tunicamycin-treated and untreated biofilms (not shown).
Together, these results seem to suggest that tunicamycin is mostly effective on growing cells as the biofilms are being formed, and the observed decreases between the control and pre-formed biofilms treated with tunicamycin could likely be explained by the effect of the antibiotic on newly produced cells and further growth of the biofilm during the additional 24 h of incubation after the addition of the drug.
Proteomic analyses of the tunicamycin effect on glycosylation of cell surface/secreted mannoproteins of C. albicans
As the outermost part of the cell, the cell surface of C. albicans mediates the host-fungus interplay. Cell surface proteins and mannoproteins play important structural and physiological roles, including virulence, morphogenesis, adherence, antigen presentation and immunomodulation. 12, 13 Using 2DE and mass spectrometry techniques, we have previously performed comparative analyses of proteinaceous materials obtained from C. albicans biofilm and planktonic cultures, including cell surface-associated proteins and secreted components present in liquid culture supernatants and the biofilm matrices. 15 These previous analyses revealed a high degree of similarity between the protein profiles associated with the planktonic and biofilm cell surface extracts, including the presence of several polydispersed, high molecular weight and highly glycosylated cell wall and secreted proteins. 15 Most notably, both C. albicans Mp65 17 and Mp58 16 represent abundant mannoproteins on the cell surface and in the biofilm matrix. 15 Due to their high levels of glycosylation, they are likely to contribute a high proportion of the carbohydrate component of the secreted materials. In addition, members of the AgglutininLike Sequence (ALS) family of cell wall proteins, particularly Als3p, are important for the adhesive interactions between biofilm cells, and these proteins are heavily glycosylated. 25, 26, 35 Thus, in this study, we were interested in investigating the effect of these physiological concentrations of tunicamycin on the protein profiles associated with cell surface/secreted proteins of C. albicans. As shown in Figure 4 (a), treatment with tunicamycin resulted in the reduction of the polydisperse nature of the regions in the gels corresponding to Mp58 and Mp65 indicated by arrows in Figure 4 (a) (the identities of these spots have been previously described by our group 15 ), a clear indication of the efficacy of the inhibition of glycosylation exerted by the antibiotic. In addition, using an ELISA, the reactivity of MAbs 3H3 and 1H4 against extracts obtained from tunicamycin-treated C. albicans cells was used to validate the removal of N-linked carbohydrate from cell surface/secreted mannoproteins by treatment with these tunicamycin concentrations. As shown in Figure 4 (b), as expected, tunicamycin treatment did not affect the reactivity of MAb 3H3 recognizing a protein epitope of C. albicans Mp58; however, the same tunicamycin treatment led to significant reductions in the level of recognition by MAb 1H4, recognizing a carbohydrate epitope in cell wall mannoproteins. Thus, both the proteomics and the ELISA results confirm the defects in glycosylation of cell surface/secreted proteins after tunicamycin treatment of C. albicans cells, which may correlate with the observed biofilm-associated phenotypes.
Conclusions
Overall, our studies indicate that, even at low concentrations, tunicamycin exhibits profound inhibitory effects on biofilm adhesion, anchoring, development and maintenance. These results add to the growing body of knowledge on the mechanisms of biofilm formation in C. albicans, 3, 6, 25, 27, 28 particularly those that are independent of filamentation-associated defects. 25 Interestingly, Peltroche-Llacsahuanga et al. 36 have previously reported on the importance of O-glycosylation of cell surface mannoproteins in biofilm formation. The effect of tunicamycin on the C. albicans biofilm mode of growth clearly indicates a potential role for the N-linked carbohydrate portion of cell wall/surface and secreted mannoproteins in the different phases of biofilm formation. The most prominent inhibitory effects of tunicamycin are on the overall process of biofilm development, as manifested in experiments in which biofilms were formed in the presence or absence of the antibiotic. The results from this series of experiments can likely be explained by N-linked glycosylation defects leading Figure 3 . Effect of tunicamycin on pre-formed C. albicans SC5314 biofilms. Tunicamycin was added to mature 24 h biofilms formed using the 96-well microtitre plate model and incubated for an additional 24 h, then assessed using the XTT reduction assay. The results are expressed as a percentage of the control biofilm (no tunicamycin). *Statistically significant differences, P,0.01. **Statistically significant differences, P,0.05.
to: (i) changes in properties of cell wall/surface mannoproteins that are likely to influence cell-cell contacts important for the overall architecture of the biofilm, similar to that described for the C. albicans Dbcr1 mutant strain; 25 -28,37 (ii) changes in cell surface hydrophobicity likely to affect both adhesion to the plastic surface and cell-cell interactions; 22 and (iii) changes in highly abundant secreted mannoproteins that constitute the major components of the biofilm matrix 15 and likely contribute the majority of the carbohydrate fraction to this exopolymeric material that is critical for biofilm integrity and maintenance. Together, these results indicate that N-linked glycosylation represents an attractive target for the development of alternative strategies for the prevention of biofilm formation that are urgently needed. w Ruby-stained 2DE gels of C. albicans cell surface components solubilized by treatment with bME from untreated cultures (top) and tunicamycin-treated cultures (2 mM) (bottom). The proteins were separated in the first dimension using a pI 4-7 gradient IPG strip followed by 12.5% SDS-PAGE. Molecular masses (MM) (in kDa) of pre-stained standard proteins run in parallel are indicated. Arrows point to poorly defined, polydispersed spots corresponding to the highly glycosylated Mp65 (arrows 1 and 2) and Mp58 (arrows 3-5), which virtually disappear after tunicamycin treatment. 
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